Microscopic polyangiitis;Polyangéite microscopique

Presse Medicale

Volumn 36, Issue 5 II, 2007, Pages 895-901

  Pagnoux, Christian ^a   Guilpain, Philippe ^a   Guillevin, Loïc ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE; RITUXIMAB;

ADJUVANT THERAPY; ANCA ASSOCIATED VASCULITIS; ANTIBODY PRODUCTION; CLINICAL FEATURE; DRUG SUBSTITUTION; GLOMERULONEPHRITIS; HUMAN; KIDNEY DISEASE; LUNG HEMORRHAGE; MAINTENANCE THERAPY; NECROTIZING ARTERITIS; NEWBORN PERIOD; NONHUMAN; PATHOGENICITY; PLACENTAL TRANSFER; PLASMAPHERESIS; POLYARTERITIS NODOSA; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RELAPSE; REMISSION; SCORING SYSTEM; SHORT SURVEY; SYMPTOM; TREATMENT FAILURE; WEGENER GRANULOMATOSIS;

EID: 34247397527     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.01.030     Document Type: Short Survey

References (52)

1. Wohwill F. Ueber die nur mikroskopisch erkennbare Form der Periarteritis nodosa. Virchows Arch pathol Anat. 246 (1923) 377-411
2. Davson J., Ball J., and Platt R. Kidney in periarteritis nodosa. Q J Med 17 (1948) 175-202
3. Lightfoot Jr. R.W., Michel B.A., Bloch D.A., Hunder G.G., Zvaifler N.J., McShane D.J., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33 (1990) 1088-1093
4. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 (1994) 187-192
5. Falk R.J., and Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318 (1988) 1651-1657
6. Serra A., Cameron J.S., Turner D.R., Hartley B., Ogg C.S., Neild G.H., et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. QJM 53 (1984) 181-207
7. D'Agati V., Chander P., Nash M., and Mancilla-Jimenez R. Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 7 (1986) 95-110
8. Adu D., Howie A.J., Scott D.G., Bacon P.A., McGonigle R.J., and Micheal J. Polyarteritis and the kidney. QJM 62 (1987) 221-237
9. Guillevin L., Durand-Gasselin B., Cevallos R., Gayraud M., Lhote F., Callard P., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42 (1999) 421-430
10. Lauque D., Cadranel J., Lazor R., Pourrat J., Ronco P., Guillevin L., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 79 (2000) 222-233
11. Savage C.O., Winearls C.G., Evans D.J., Rees A.J., and Lockwood C.M. Microscopic polyarteritis: presentation, pathology and prognosis. QJM 56 (1985) 467-483
12. Lane S.E., Watts R.A., Shepstone L., and Scott D.G. Primary systemic vasculitis: clinical features and mortality. QJM 98 (2005) 97-111
13. Watts R.A., Gonzalez-Gay M.A., Lane S.E., Garcia-Porrua C., Bentham G., and Scott D.G. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 60 (2001) 170-172
14. Mahr A., Guillevin L., Poissonnet M., and Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51 (2004) 92-99
15. Jennette J.C., Wilkman A.S., and Falk R.J. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135 (1989) 921-930
16. Guilpain P., Chanseaud Y., Tamby M.C., Mahr A., Servettaz A., Guillevin L., et al. Pathogénie des vascularites systémiques primitives (I) : vascularites ANCA-positives. Presse Med 34 (2005) 1013-1022
17. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110 (2002) 955-963
18. Bansal P.J., and Tobin M.C. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93 (2004) 398-401
19. Falk R.J., Hogan S., Carey T.S., and Jennette J.C. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 113 (1990) 656-663
20. Xiao H., Heeringa P., Liu Z., Huugen D., Hu P., Maeda N., et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167 (2005) 39-45
21. Tamby M.C., Humbert M., Guilpain P., Servettaz A., Dupin N., Christner J.J., et al. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Respir J 28 (2006) 799-807
22. Chanseaud Y., Pena-Lefebvre P.G., Guilpain P., Mahr A., Tamby M.C., Uzan M., et al. IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin Immunol 109 (2003) 165-178
23. Carvalho D., Savage C.O., Isenberg D., and Pearson J.D. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 42 (1999) 631-640
24. Hogan S.L., Nachman P.H., Wilkman A.S., Jennette J.C., and Falk R.J. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7 (1996) 23-32
25. Kapitsinou P.P., Ioannidis J.P., Boletis J.N., Sotsiou F., Nakopoulou L., Daphnis E., et al. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis 41 (2003) 29-37
26. Zauner I., Bach D., Braun N., Kramer B.K., Funfstuck R., Helmchen U., et al. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis. Am J Kidney Dis 39 (2002) 28-35
27. Hefty T.R., Bonafede P., and Stenzel P. Bilateral ureteral stricture from polyarteritis nodosa. J Urol 141 (1989) 600-601
28. Kaskarelis I.S., Zarifi M., Dantis P., and Vrachliotis G. Bilateral ureteral involvement in polyarteritis nodosa. Scand J Urol Nephrol 29 (1995) 323-326
29. Azar N., Guillevin L., Huong Du L.T., Herreman G., Meyrier A., and Godeau P. Symptomatic urogenital manifestations of polyarteritis nodosa and Churg-Strauss angiitis: analysis of 8 of 165 patients. J Urol 142 (1989) 136-138
30. Guillevin L., Lhote F., Amouroux J., Gherardi R., Callard P., and Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol 35 (1996) 958-964
31. Eschun G.M., Mink S.N., and Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 123 (2003) 297-301
32. Homma S., Matsushita H., and Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 9 (2004) 190-196
33. Homas P.B., David-Bajar K.M., Fitzpatrick J.E., West S.G., and Tribelhorn D.R. Microscopic polyarteritis. Report of a case with cutaneous involvement and antimyeloperoxidase antibodies. Arch Dermatol 128 (1992) 1223-1228
34. Caster J.C., Shetlar D.J., Pappolla M.A., and Yee R.W. Microscopic polyangiitis with ocular involvement. Arch Ophthalmol 114 (1996) 346-348
35. Gordon M., Luqmani R.A., Adu D., Greaves I., Richards N., Michael J., et al. Relapses in patients with a systemic vasculitis. QJM 86 (1993) 779-789
36. WGET, and Wegener's Granulomatosis Etanercept Trial Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352 (2005) 351-361
37. Jayne D.R., Rasmussen N., Andrassy K., Bacon P., Tervaert J.W., Dadoniene J., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349 (2003) 36-44
38. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75 (1996) 17-28
39. Gayraud M., Guillevin L., le Toumelin P., Cohen P., Lhote F., Casassus P., et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44 (2001) 666-675
40. Pagnoux C., Mahr A., Cohen P., and Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, wegener granulomatosis, churg-strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 84 (2005) 115-128
41. Guillevin L., and Pagnoux C. Indications of plasma exchanges for systemic vasculitides. Ther Apher Dial 7 (2003) 155-160
42. Langford C.A., Klippel J.H., Balow J.E., James S.P., and Sneller M.C. Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity. Ann Intern Med 129 (1998) 49-58
43. Haubitz M., Schellong S., Gobel U., Schurek H.J., Schaumann D., Koch K.M., et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum 41 (1998) 1835-1844
44. Gayraud M., Guillevin L., Cohen P., Lhote F., Cacoub P., Deblois P., et al. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides. Br J Rheumatol 36 (1997) 1290-1297
45. Guillevin L., Cohen P., Mahr A., Arene J.P., Mouthon L., and Puechal X. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 49 (2003) 93-100
46. Stegeman C.A., Tervaert J.W., de Jong P.E., and Kallenberg C.G. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 335 (1996) 16-20
47. Jayne D.R. How to induce remission in primary systemic vasculitis. Best Pract Res Clin Rheumatol. 19 (2005) 293-305
48. Guillevin L., and Pagnoux C. When should immunosuppressants be prescribed to treat systemic vasculitides?. Intern Med 42 (2003) 313-317
49. Jayne D.R., Chapel H., Adu D., Misbah S., O'Donoghue D., Scott D., et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93 (2000) 433-439
50. Bartolucci P., Ramanoelina J., Cohen P., Mahr A., Godmer P., Le Hello C., et al. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford) 41 (2002) 1126-1132
51. Keogh K.A., Wylam M.E., Stone J.H., and Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52 (2005) 262-268
52. Keogh K.A., Ytterberg S.R., Fervenza F.C., Carlson K.A., Schroeder D.R., and Specks U. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173 (2006) 180-187